Abraján-Hernández OI, Castañón-González JA, León-Gutiérrez MA, Tejeda-Huezo B, Sánchez-Hurtado L, Serrano-Cuevas L, Hernández-Ramírez DA

Language: Spanish
References: 17
Page: 545-548
PDF size: 61.33 Kb.

ABSTRACT

Acute colonic pseudo-obstruction or “Ogilvie syndrome (OS),” is a gastrointestinal motility disorder characterized by marked dilatation of the colon in the absence of mechanical obstruction. It occurs most commonly in the postoperative state or with severe medical illness; it has been associated with a wide range of comorbidities, including trauma, pelvic surgery (orthopedic, gynecologic, urologic), metabolic disorders, central nervous system disorders, and prostaglandin abnormalities. OS may also be drug induced or idiopathic. Left untreated, it can progress to perforation, peritonitis, and death. Definitive management of OS traditionally has consisted of mechanical decompression. However, neostigmine, an acetyl-cholinesterase inhibitor, has recently emerged as a safe and effective pharmacologic alternative in the adult population. We present two cases of OS attended in the intensive care unit treated with colonoscopy and cecostomy respectively.

REFERENCES

1. Ogilvie H. Large intestine colic due to sympathetic deprivation: a new clinical syndrome. Br Med J 1948;2(4579):671-673.

2. Eisen G, Baron T, Dominitz J, Faigel DO, Goldstein JL, Johanson JF, et al. Acute colonic pseudo-obstruction. Gastrointest Endosc 2002;56(6):789-792.

3. Vantrappen G. Acute colonic pseudo-obstruction. Lancet 1993;34(8838)1:152- 153.

4. Tenofsky P, Beamer L, Smith S. Ogilvie syndrome as a postoperative complication. Arch Surg 2000;135(6):682-687.

5. Quintero I, Cachafeiro M, Valdovinos M. Síndrome de Ogilvie o pseudoobstrucción colónica aguda. Conceptos actuales en diagnóstico y tratamiento. Rev Gastroenterol Mex 1997;62(2): 119-127.

6. Fraise A, Brosse S, Manckoundia P. Ogilvie syndrome in the elderly: retrospective study of 40 cases. Press Med 2003;32(32):1500-1504.

7. Arranz-Caso J, García-de Tena J, Cuadrado LM, Botella M. Prolonged colonic pseudo-obstruction (Ogilvie syndrome) in an older woman resolved with conservative treatment. J Am Geriatr Soc 1996: 44(8):1016-1017.

8. Reynolds J. Challenges in the treatment of colonic motility disorders. Am J Health Sys Pharm 1996; 53(22 Suppl 3):S17-S26.

9. Shand A, Kamm M. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther 2004;19(6):687-694.

10. Hutchinson R, Griffiths C. Acute colonic pseudoobstruction pharmacological approach. Ann R Coll Surg Engl 1992;74(5):364-367.

11. Turegano-Fuentes F, Muñoz-Jiménez F, Del Valle- Hernández E, Pérez-Díaz D, Calvo-Serrano M, De Tomas J. Early resolution of Ogilvie’s syndrome with intravenous neostigmine: a simple, effective treatment. Dis Colon Rectum 1997:40(11):1353-1357.

12. Ponec R, Saunders M, Kimmey M. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med 1999;341(3):137-141.

13. Althausen P, Gupta M, Benson D, Jones D. The use of neostigmine to treat postoperative ileus in orthopedic spinal patients. J Spin Dis 2001;14(6): 541-545.

14. Isbister G, Oakley P, Whyte I, Dawson A. Treatment of anticholinergic-induced ileus with neostigmine. Ann Emerg Med 2001;38(6):689-693.

15. Rex D. Colonoscopy and acute colonic pseudoobstruction. Gastrointest Endosc Clin N Am 1997; 7(3):499-508.

16. O’Malley KJ, Flechner SM, Kapoor A, Rhodes RA, Modlin CS, Goldfarb DA, et al. Acute colonic pseudoobstruction (Ogilvie’s syndrome) after renal transplantation. Am J Surg 1999;177(6):492-4 96.

17. Uno Y. Percutaneous endoscopic cecostomy and antegrade continence enema by use of the chain trapdoor cecostomy catheter in patients with adult neurogenic bowel. Gastrointest Endosc 2006;63 (4):666-673.